Your browser doesn't support javascript.
loading
A Prospective Study Regarding the Efficacy and Safety of the BNT162b2 Vaccine in Patients With Solid Malignancies Undergoing Systemic Chemotherapy.
Yamasaki, Eiki; Shimamoto, Fukutaro; Nishikawa, Hiroki; Goto, Masahiro; Iwamoto, Mitsuhiko; Kimura, Kosei; Ukimura, Akira; Oosaka, Naofumi; Taniguchi, Kohei; Ono, Fumihito; Terazawa, Tetsuji; Yamaguchi, Toshifumi; Asaishi, Ken; Ikegami, Takako; Uchiyama, Kazuhisa; Nakamura, Shiro; Higuchi, Kazuhide.
Afiliação
  • Yamasaki E; Second Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
  • Shimamoto F; Cancer Chemotherapy Center, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
  • Nishikawa H; Second Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Takatsuki, Japan; nishikawa_6392_0207@yahoo.co.jp.
  • Goto M; Premier Departmental Research of Medicine, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
  • Iwamoto M; Cancer Chemotherapy Center, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
  • Kimura K; Department of Breast Surgery, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
  • Ukimura A; Department of Breast Surgery, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
  • Oosaka N; Third Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
  • Taniguchi K; Department of Central Clinical Laboratory, Osaka Medical and Pharmaceutical University, Osaka, Japan.
  • Ono F; Translational Research Program, Osaka Medical and Pharmaceutical University, Osaka, Japan.
  • Terazawa T; Translational Research Program, Osaka Medical and Pharmaceutical University, Osaka, Japan.
  • Yamaguchi T; Cancer Chemotherapy Center, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
  • Asaishi K; Cancer Chemotherapy Center, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
  • Ikegami T; Cancer Chemotherapy Center, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
  • Uchiyama K; Second Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
  • Nakamura S; Dean, Osaka Medical and Pharmaceutical University, Osaka, Japan.
  • Higuchi K; Second Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
In Vivo ; 36(6): 2780-2789, 2022.
Article em En | MEDLINE | ID: mdl-36309395

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas / COVID-19 / Neoplasias Tipo de estudo: Observational_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas / COVID-19 / Neoplasias Tipo de estudo: Observational_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article